Madrigal Pharmaceuticals (acquired by Synta Pharmaceuticals)'s Seed VC Round

Madrigal Pharmaceuticals (acquired by Synta Pharmaceuticals) raised a round of funding on September 02, 2011. Investors include Bay City Capital.

Madrigal Pharmaceuticals is a company focused on the development of novel compounds for the treatment of cardiovascular-metabolic diseases and nonalcoholic steatohepatitis (NASH). The Company's lead c…

Articles about Madrigal Pharmaceuticals (acquired by Synta Pharmaceuticals)'s Seed VC Round: